How many clinical trials are there for BCR-ABL1 Positive?

PlainTrial tracks 1 US clinical trials for BCR-ABL1 Positive, of which 1 are currently recruiting.

Which interventions appear most often on BCR-ABL1 Positive trial records?

Dasatinib is the most-linked intervention name on BCR-ABL1 Positive records (1 trial links), followed by Decitabine and Cedazuridine. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for BCR-ABL1 Positive?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

BCR-ABL1 Positive: early-phase trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed BCR-ABL1 Positive trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

BCR-ABL1 Positive: 1 US clinical trial tracked, 1 recruiting.

BCR-ABL1 Positive is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition bcr-abl1-positive

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near BCR-ABL1 Positive

BCR-ABL1 Positive lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for BCR-ABL1 Positive on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

BCR-ABL1 Positive is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 2 70 participants

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

M.D. Anderson Cancer Center

NCT05007873

Phase Distribution

Phase	Trial count
Phase 2	1

Top Sponsors

M.D. Anderson Cancer Center 1 trials

Named interventions

Most-linked intervention names on BCR-ABL1 Positive records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Dasatinib Drug

1 trials

Decitabine and Cedazuridine Drug

1 trials

US sites by state

Facility locations filed on BCR-ABL1 Positive trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this BCR-ABL1 Positive page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 BCR-ABL1 Positive trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
M.D. Anderson Cancer Center sponsors the most BCR-ABL1 Positive trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This BCR-ABL1 Positive condition card totals 1 registered trials; most-linked intervention Dasatinib; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.